Tumor sialylation is a barrier against CD8 T cell-mediated anti-tumor responses and anti-PD-1 resistance in breast cancer
Stefan Mereiter, Gustav Jonsson, Tiago Oliveira, Johannes Helm, David Hoffmann, Markus Abeln, Ann-Kristin Jochum, Wolfram Jochum, Max J. Kellner, Marek Feith, Vanessa Tkalec, Karolina Wasilewska, Jie Jiao, Lukas Emsenhuber, Felix Holstein, Anna C. Obenauf, Leonardo Lordello, Jean–Yves Scoazec, Guido Guido Kroemer, Laurence Zitvogel, Omar Hasan Ali, Lukas Flatz, Rita Gerardy‐Schahn, Anja Muenster-Kuehnel, Johannes Stadlmann, Josef Penninger (2023). Tumor sialylation is a barrier against CD8 T cell-mediated anti-tumor responses and anti-PD-1 resistance in breast cancer. , DOI: https://doi.org/10.1101/2023.09.20.558571.
